A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial

Nina Possemis
, Frans Verhey
, Jos Prickaerts
, Arjan Blokland
, Inez Ramakers^*

^*Corresponding author for this work

Basic Neuroscience 2
MHeNs - Neuroscience
Psychiatrie & Neuropsychologie
MHeNs - Cognitive Neuropsychiatry and Clinical Neuroscience
MA Med Staf Spec Psychiatrie
Psychopharmacology
Section Psychopharmacology
MA Niet Med Staf Psychologie i.o.
Psychology 2

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial'. Together they form a unique fingerprint.

A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial

Fingerprint

Keyphrases

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

INIS

Biochemistry, Genetics and Molecular Biology